Skip to main content

Enovis Corp

Exchange: NYSESector: IndustrialsIndustry: Specialty Industrial Machinery

and ESAB Corporation Colfax Corporation is a leading diversified technology company that provides orthopedic and fabrication technology products and services to customers around the world, principally under the DJO and ESAB brands. The Company uses its Colfax Business System, a comprehensive set of tools and processes, to create superior value for customers, shareholders and associates. In March of 2021, Colfax announced its intention to separate into two independent and public companies to accelerate strategic momentum and unlock additional value creation potential. The Company recently announced that it expects to complete the Separation on April 4, 2022 and will then operate under the name Enovis Corporation. Enovis Corporation (NYSE: ENOV) will be an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. ESAB Corporation (NYSE: ESAB) is a world leader in fabrication and specialty gas control technology, providing its partners with advanced equipment, consumables, automation, robotics, and digital solutions which enable the everyday and extraordinary work that shapes our world.

Did you know?

Carries 37.2x more debt than cash on its balance sheet.

Current Price

$23.62

+0.77%

GoodMoat Value

$62.36

164.0% undervalued
Profile
Valuation (TTM)
Market Cap$1.35B
P/E-1.14
EV
P/B0.91
Shares Out57.19M
P/Sales0.60
Revenue$2.25B
EV/EBITDA

Enovis Corp (ENOV) Quality Analysis

ENOV GoodMoat Verdict

Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.

ENOV Profitability

Profitability trend analysis coming soon

ENOV Growth

Growth trend analysis coming soon

ENOV Financial Health

Financial health indicators coming soon

ENOV Quality & Fundamental Analysis

Enovis Corp (ENOV) is a Industrials company in the Specialty Industrial Machinery industry, listed on NYSE. This quality analysis page evaluates Enovis Corp's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.

Enovis Corp has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of -52.69% and a return on equity (ROE) of -79.51%. Return on assets (ROA) stands at -30.89%.

The debt-to-equity ratio is 0.91, with a current ratio of 2.02. Operating margin is -50.01%.

GoodMoat's quality analysis uses AI-powered insights to evaluate whether Enovis Corp is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.